Select Publications

Gradishar W et al. A randomized phase 2 trial of qw or q3w ABI-007 (ABX) vs q3W solvent-based docetaxel (TXT) as first-line therapy in metastatic breast cancer (MBC). Presentation. San Antonio Breast Cancer Symposium 2006;Abstract 46.

McArthur HL et al. Cardiac safety of adjuvant bevacizumab plus dose-dense doxorubicin/cyclophosphamide followed by nanoparticle albumin-bound paclitaxel in patients with early stage breast cancer. Poster. San Antonio Breast Cancer Symposium 2007;Abstract 3065.

Miller KD et al. Phase II feasibility trial incorporating bevacizumab into dose dense doxorubicin and cyclophosphamide followed by paclitaxel in patients with lymph node positive breast cancer: A trial of the Eastern Cooperative Oncology Group (E2104). San Antonio Breast Cancer Symposium 2007;Abstract 3063.

Schneider B et al. Association of genetic polymorphisms of VEGF and VEGFR-2 with outcome in E2100. Poster. San Antonio Breast Cancer Symposium 2007;Abstract 1107.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Home · Search

EDITOR'S NOTE
San Antonio adventure, 2007
Neil Love, MD
- Select publications

INTERVIEWS
Stephen E Jones, MD
- Select publications

Sir Richard Peto, FRS
- Select publications

Kathy S Albain, MD
- Select publications

Roundtable Discussion
- Select publications

Joyce O’Shaughnessy, MD
- Select publications

Nancy U Lin, MD
- Select publications

Breast Cancer Update:
A CME Audio Series and Activity

Editor's Office

Faculty Disclosures